Duloxetine for perimenopausal depression
Phase of Trial: Phase IV
Latest Information Update: 07 Jul 2012
At a glance
- Drugs Duloxetine (Primary)
- Indications Depressive disorders; Menopausal syndrome
- Focus Therapeutic Use
- 07 Jul 2012 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
- 07 Jul 2012 Actual patient number is 7 according to ClinicalTrials.gov.
- 07 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.